<DOC>
	<DOCNO>NCT00852761</DOCNO>
	<brief_summary>The purpose study determine efficacy safety two different form topical steroid ( clobetasol propionate ) patient plaque-type psoriasis .</brief_summary>
	<brief_title>A Study Evaluate Efficacy Tolerability Topical Therapies Condition Plaque-Type Psoriasis</brief_title>
	<detailed_description>This study conduct obtain efficacy tolerability data two clobetasol propionate therapy treatment plaque-type psoriasis . Subjects randomize one two therapy treatment throughout study .</detailed_description>
	<mesh_term>Psoriasis</mesh_term>
	<mesh_term>Clobetasol</mesh_term>
	<criteria>Body surface area ( BSA ) affect psoriasis 4 % 20 % . Target lesion least 2 cmÂ² elbow and/or knee , score 2 3 Psoriasis Grading Scale Target Lesion . Elbow and/or knee plaquetype psoriasis Psoriasis Global Assessment mild moderate ( 2 3 ) . Definitive diagnosis elbow and/or knee plaquetype psoriasis . Capable understanding willing provide sign dated write voluntary inform consent ( local national authorization requirement ) protocolspecific procedure perform . Male female , 18 year age old time consent form sign . Able complete study comply study instruction . Female subject childbearing potential must negative pregnancy test . Sexually active woman childbearing potential participating study must use medically acceptable form contraception . Use emollient apply psoriasis plaque treat study medication study . Other serious skin disorder chronic medical condition well control . Female subject pregnant , try become pregnant lactating . Any major illness within 30 day prior baseline visit . Received investigational drug treatment within 30 day baseline visit schedule receive investigational drug treatment study product study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2012</verification_date>
	<keyword>Psoriasis</keyword>
</DOC>